Skip to content

The VESPA study: Vendor-specific features of clinical ASL-MRI

The VESPA study: Vendor-specific features of clinical ASL-MRI - VESPA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37480
Enrollment
20
Registered
2012-06-29
Start date
2012-07-06
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geen aandoening Er wordt geen aandoening bestudeerd.

Interventions

200 mg. cafeine per scan

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • healthy adult volunteers, between 18 to 40 years of age • non-smoking • informed consent

Exclusion criteria

Exclusion criteria: • inability of the patient to provide informed consent or legally incompetent/incapacitated to do so • presence of metal in the body (e.g. osteosynthetic material, pacemaker, artificial cardiac valves) • claustrophobia • history of brain surgery • history of brain or psychiatric disease • use of medication with the exception of oral contraceptives.

Design outcomes

Primary

MeasureTime frame
CBF (mL per 100 grams of brain tissue per minute) as assessed by ASL at 3.0 T MRI

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)